# PAR HAWAII REFINING, LLC — Warning Letter

- **operation:** document
- **citation:** CPF 22024013WL
- **title:** PAR HAWAII REFINING, LLC — Warning Letter
- **source type:** enforcement
- **agency:** Pipeline and Hazardous Materials Safety Administration
- **status:** historical
- **official:** true
- **published on:** 2024-08-23
- **effective on:** Not available
- **summary:** CLOSED warning letter citing 40.25(a), 40.347(b)(2).
- **machine formats:** - **json:** https://regulus.evalyn.ai/document/phmsa-enforcement-22024013wl.json
- **markdown:** https://regulus.evalyn.ai/document/phmsa-enforcement-22024013wl.md
- **app url:** https://regulus.evalyn.ai/document/phmsa-enforcement-22024013wl
- **source url:** https://primis.phmsa.dot.gov/enforcement-data/case/22024013WL
**body:**

Warning Letter involving PAR HAWAII REFINING, LLC. PHMSA's enforcement data identifies the cited regulations as 40.25(a),  40.347(b)(2). The case was opened on 2024-08-23 and is reported as closed as of 2024-08-23. Open the official case record for notices, responses, orders, and the latest status.

Official case documents:

22024013WL_Warning Letter_08232024_(24-304839).pdf: https://primis.phmsa.dot.gov/enforcement-documents/22024013WL/22024013WL_Warning%20Letter_08232024_(24-304839).pdf

22024013WL_Warning Letter_08232024_(24-304839)_text.pdf: https://primis.phmsa.dot.gov/enforcement-documents/22024013WL/22024013WL_Warning%20Letter_08232024_(24-304839)_text.pdf

22024013WL_Warning Letter_08232024_(24-304839)_text.pdf

WARNING LETTER
VIA ELECTRONIC MAIL TO: ewright@parpacific.com; MLoveless@parpacific.com;
MBurns@parpacific.com.
August 23, 2024
Eric Wright
Vice President
Par Hawaii Refining, LLC
1132 Bishop Street, Suite 2500
Honolulu, HI 96813
CPF 2-2024-013-WL
Dear Mr. Wright:
From April 10 through June 5, 2024, a representative of the Pipeline and Hazardous Materials
Safety Administration (PHMSA), Office of Pipeline Safety (OPS), pursuant to Chapter 601 of
49 United States Code (U.S.C.), inspected the Par Hawaii Refining, LLC (Par Hawaii), Drug and
Alcohol (D&A) program using email and other virtual methods.
As a result of the inspection, it is alleged that Par Hawaii has committed probable violations of
the Pipeline Safety Regulations, Title 49, Code of Federal Regulations (CFR).
1 The items
inspected and the probable violations are as follows:
1. § 40.25 Must an employer check on the drug and alcohol testing record of employees it
is intending to use to perform safety-sensitive duties?
(a)(1) Yes, as an employer, you must, after obtaining an employee’s written consent,
request the information about the employee listed in paragraphs (b) through (j) of this
section. This requirement applies only to employees seeking to begin performing safety-
sensitive duties for you for the first time (i.e., a new hire, an employee transferring into
a safety-sensitive position). If the employee refuses to provide this written consent, you
1 The PHMSA regulations in 49 C.F.R. § 199.5 state that violations of the DOT Procedures in 49 CFR Part 40 are
violations of 49 CFR Part 199 with respect to the anti-drug and alcohol programs required by Part 199.



2. must not permit the employee to perform safety-sensitive functions.
Par Hawaii did not obtain an employee's written consent and did not request the information
listed in paragraphs (b) through (j) of § 40.25 about employees seeking to begin performing
safety-sensitive duties for Par Hawaii for the first time (i.e., a new hire or an employee
transferring into a safety-sensitive position).
The regulations in § 40.25 require an employer to first obtain an employee’s written consent
and then to request the information listed in § 40.25(b) through (j) from DOT-regulated
employers who employed the employee during any period during the two years before the
date of the employee's application or transfer into a safety-sensitive position, which the
PHMSA regulations in Part 199 refer to as covered employees.
Par Hawaii's 2022 Management Information System (MIS) report showed three employees
had been given DOT/PHMSA pre-employment drug tests and hired in 2022 to perform
covered functions. Par Hawaii also hired trainees who, after completing the required training,
were transferred to perform covered functions.
PHMSA requested copies of the written consent forms that should have been signed by the
three employees listed on the MIS report and by the employees hired as trainees and then
transferred to perform covered functions. PHMSA also asked for a redacted copy of the
D&A background checks of these employees. Par Hawaii responded that they did not have
the records requested.
§ 40.347 What functions may C/TPAs perform with respect to administering testing?
As a C/TPA, except as otherwise specified in this part, you may perform the following
functions for employers concerning random selection and other selections for testing.
(a) …
(b)(2) Employees not covered by DOT agency regulations may not be part of the same
random pool with DOT covered employees.
Par Hawaii’s third-party administrator (TPA) included employees not covered by DOT-
agency (i.e., PHMSA) regulations in the same drug random pool with DOT covered
employees.
Par Hawaii failed to differentiate its PHMSA “covered employees” as defined in § 199.3
from its non-DOT employees. As a result, the TPA included in its random drug testing pool
for calendar year (CY) 2023 employees who were not DOT-regulated employees.
In CY 2023, Par Hawaii reported 138 covered employees. After discussing with the operator
the specifics of what defines a covered employee under § 199.3 and an internal reevaluation,
Par Hawaii determined that only 67 of the 138 employees worked on the 24-mile PHMSA
regulated pipeline in CY 2023.
Under 49 U.S.C. § 60122 and 49 CFR § 190.223, you are subject to a civil penalty not to exceed
$266,015 per violation per day the violation persists, up to a maximum of $2,660,135 for a
related series of violations. For violation occurring on or after January 6, 2023 and before
December 28, 2023, the maximum penalty may not exceed $257,664 per violation per day the
violation persists, up to a maximum of $2,576,627 for a related series of violations. For violation
occurring on or after March 21, 2022, and before January 6, 2023, the maximum penalty may not
exceed $239,142 per violation per day the violation persists, up to a maximum of $2,391,412 for



a related series of violations. For violation occurring on or after May 3, 2021, and before March
21, 2022, the maximum penalty may not exceed $225,134 per violation per day the violation
persists, up to a maximum of $2,251,334 for a related series of violations. For violation
occurring on or after January 11, 2021, and before May 3, 2021, the maximum penalty may not
exceed $222,504 per violation per day the violation persists, up to a maximum of $2,225,034 for
a related series of violations. For violation occurring on or after July 31, 2019, and before
January 11, 2021, the maximum penalty may not exceed $218,647 per violation per day the
violation persists, up to a maximum of $2,186,465 for a related series of violations. For violation
occurring on or after November 27, 2018, and before July 31, 2019, the maximum penalty may
not exceed $213,268 per violation per day, with a maximum penalty not to exceed $2,132,679.
We have reviewed the circumstances and supporting documents involved in this case and have
decided not to conduct additional enforcement action or penalty assessment proceedings at this
time. We advise you to promptly correct these item. Failure to do so may result in Par Hawaii
being subject to additional enforcement action.
No reply to this letter is required. If you choose to reply, in your correspondence please refer to
CPF 2-2024-013-WL. Be advised that all material you submit in response to this enforcement
action is subject to being made publicly available. If you believe that any portion of your
responsive material qualifies for confidential treatment under 5 U.S.C. § 552(b), along with the
complete original document you must provide a second copy of the document with the portions
you believe qualify for confidential treatment redacted and an explanation of why you believe
the redacted information qualifies for confidential treatment under 5 U.S.C. § 552(b).
Sincerely,
James A. Urisko
Director, Southern Region, Office of Pipeline Safety
Pipeline and Hazardous Materials Safety Administration
Enclosures: Response Options for Pipeline Operators in Enforcement Proceedings
- **truncated:** false
- **body characters:** 7768
